Differences

This shows you the differences between two versions of the page.

--- robyn_harrison [2022/03/29 15:21]
liam
+++ robyn_harrison [2022/03/29 16:58] (current)
liam [COVID-19]
@@ Line 3: / Line 3: @@
 {{ ::dr_harrison_8-e1598373087118-250x250.jpeg?150|}}
-Dr. **Robyn Alana Harrison**, MD, MSc, FRCPC, is a Canadian infectious diseases specialist based in Edmonton, Alberta. She speaks English and French.
+Dr. **Robyn Alana Harrison**, MD, MSc, FRCPC, is a Canadian [[infectious diseases]] specialist based in Edmonton, Alberta. She speaks English and French.((//Doctor Harrison Robyn Alana Infectious diseases specialist in Edmonton.// Doctor of Alberta. Retrieved March 21, 2022, from https://archive.ph/XfnWc))
-She is notable in the COVID-19 pandemic due to her role as Vice-chair of the National Advisory Committee on Immunization (NACI).
+She is notable in the [[COVID-19 pandemic]] due to her role as Vice-chair of the [[National Advisory Committee on Immunization]] (NACI).
+===== Education =====
+Dr. Harrison obtained her medical degree at [[Dalhousie University]], and completed her Internal Medicine and Infectious Diseases subspecialty training at the [[University of Alberta]]. Most recently, she completed an MSc in the combined areas of [[Public Health]] and [[Epidemiology]] through the [[London School of Hygiene and Tropical Medicine]].
+===== Affiliations =====
+==== University of Alberta ====
+Dr. Harrison is a Clinical Professor in the Faculty of Medicine & Dentistry at the [[University of Alberta]].((//Robyn Harrison, MD, MSc, FRCPC.// Directory@UAlberta; University of Alberta. Retrieved March 21, 2022, from https://archive.ph/Rdb4X)) She also practices at the [[University of Alberta Hospital]], at least as recently as 2014.((//The AATHP Annual Travel Health Symposium & General Meeting 2014 (p. 3).// (2014). Alberta Association of Travel Health Professionals. https://web.archive.org/web/20220321181523/http://aathp.com/AATHP_conf_2014.pdf))
+The U of A Hospital is funded through the [[University Hospital Foundation]] by [[pharmaceutical_companies:Astellas Pharma]], [[Bell Media]], [[pharmaceutical_companies:Biogen]], [[pharmaceutical_companies:BIOTECanada]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Canadian National Railway]] (a [[Bill Gates|Bill]] and [[Melinda Gates|Melinda]] Gates company), [[Corus Entertainment]], [[CTV]], [[Cystic Fibrosis Canada]], [[Deloitte]], [[Ernst & Young LLP]], [[Fidelity Investments]], [[Global News]], [[pharmaceutical_companies:Janssen]], [[KPMG]], [[London Drugs]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[PricewaterhouseCoopers]], [[RBC (Royal Bank of Canada)]]/RBC Foundation, [[pharmaceutical_companies:Roche]], [[Scotiabank]], [[pharmaceutical_companies:Servier]], [[Suncor Energy]], [[Sun Life Financial]], [[pharmaceutical_companies:Takeda]], [[TELUS]], [[University of Calgary]], [[Volvo]], and [[WestJet]].((Abbott, J. L. (2021). //Thank you to our donors.// University Hospital Foundation. https://web.archive.org/web/20220128195634/https://givetouhf.ca/app/uploads/2021/12/UHF-2021-HonouringDonors-WEB-v2.pdf)) ((Abbott, J. L. (2020). //Annual Report 2019-2020.// University Hospital Foundation. https://web.archive.org/web/20220109041602/https://givetouhf.ca/app/uploads/2021/08/UHF_Annual-Report-2019-2020-Revised_19412_F-pages-smaller.pdf)) ((Brown, J. (2019). //Annual Report 2018-2019.// University Hospital Foundation. https://web.archive.org/web/20220109041607/https://givetouhf.ca/app/uploads/2020/10/UHF-Annual-Report-2018-19-lowres.pdf))
+Many of these are member organizations of the [[World Economic Forum]], and the others listed have been demonstrated to have a degree of conflict of interest (real or perceived) in influencing the [[COVID-19 pandemic]] response.((//Partners.// World Economic Forum. Retrieved March 21, 2022, from https://web.archive.org/web/20220319000719/https://www.weforum.org/partners)) This includes [[financial institutions]], [[pharmaceutical companies]], and [[media]].
+==== Covenant Health ====
+Dr. Harrison practices medicine as an infectious diseases and internal medicine specialist at [[Grey Nuns Community Hospital]] under [[Covenant Health]].((//Dr. Harrison - Doctor Robyn Alana Harrison - 2275-1100 Youville Drive West NW Grey Nuns Hospital, Edmonton, Alberta.// Alberta Doctor Directory. Retrieved March 21, 2022, from https://archive.ph/rGesh)) ((//Grey Nuns Community Hospital.// Alberta Health Services. Retrieved March 21, 2022, from https://archive.ph/sZQ4e)) She also served as consultant for the Covenant Health Alberta Occupational Health and Safety Program from 2008-2014.
+==== Alberta Health Services (2009-current) ====
+Dr. Harrison is a Communicable Disease Consultant for the province-wide [[public_health_agencies:canada:Alberta Health Services]] Workplace Health and Safety Program, a position she has held since 2009. In this role, she co-authored an open letter addressing concerns and “[[misinformation]]” about the safety of the [[:COVID-19_vaccines|COVID-19 injections]] alongside members of the AHS Scientific Advisory Group, including [[:public_health_agencies:canada:Lynora Saxinger]] and [[:public_health_agencies:canada:John Conly]].((Constantinescu, C., Kellner, J. D., Conly, J., Klein, K., Saxinger, L. M., Wickland-Weller, M., Harrison, R., & Smith, S. W. (2021). //An open letter in response to vaccine concerns and misinformation.// Alberta Health Services. https://web.archive.org/web/20220321163612/https://www.albertahealthservices.ca/assets/news/nr/ne-nr-2021-10-01-response-vaccine-concerns-misinformation.pdf)) The letter was published on October 1st, 2021.
+==== Alberta Advisory Committee on Immunization (2015-present) ====
+Dr. Harrison is a member of the [[Alberta Advisory Committee on Immunization]], and she participates in infection prevention working groups in the province of Alberta, including past work on pandemic influenza [[H1N1]] in 2009, and [[avian influenza]] in 2014.
+==== Royal Society of Canada ====
+Dr. Harrison was recruited to the [[royal_society_of_canada:RSC Task Force on COVID-19]] by the President of the [[Royal Society of Canada]] in April 2020. The group was established to rapidly create policy briefings. In February 2021, she co-authored a report titled “The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era.”((Sligl, W., Waldner, D., Johnstone, J., Harrison, R., Webster, D., & Saxinger, L. (2021, February). //The epidemiology of COVID-19 in Canada in 2020: the pre-vaccine era.// Royal Society of Canada. https://www.interacademies.org/sites/default/files/2021-02/Epid%20PB_EN.pdf))
+==== National Advisory Committee on Immunization (2017-current) ====
+Dr. Harrison began as a member of the [[National Advisory Committee on Immunization]] (NACI) in September 2017, and has served as Chair of the [[Hepatitis]] and [[Influenza]] working groups.((Public Health Agency of Canada. (2021, June 15). //Statement from the Public Health Agency of Canada Announcing the New Chair and Vice-Chair of the National Advisory Committee on Immunization.// Direct Source News; Wayback Machine. https://archive.ph/YBohl)) On December 19, 2020, she delivered a presentation hosted by [[CANVax]] and the [[National Collaborating Centre for Infectious Diseases]] to inform health care workers about NACI’s [[Pfizer-BioNTech COVID-19 vaccine]] recommendations.((NCCID. (2020, December 11). //Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Pfizer-BioNTech COVID-19 vaccine.// National Collaborating Centre for Infectious Diseases. https://archive.ph/StT0O)) ((NCCID • CCNMI. (2020, December 19). //Recommendations of NACI on the Use of the Pfizer BioNTech COVID 19 Vaccine.// YouTube. https://www.youtube.com/watch?v=0sE-si0XW3k)) She was appointed as the Vice-chair of NACI in June 2021.((Public Health Agency of Canada. (2021, June 7). //Statement from the Public Health Agency of Canada Announcing the New Chair and Vice-Chair of the National Advisory Committee on Immunization.// Government of Canada. https://archive.ph/rWLid)) On June 18, she participated in a French language webinar for the [[Canadian Association of Physician Assistants]] on the topic of [[COVID-19 vaccines|COVID-19 vaccine]] interchangeability.((//Upcoming Events CAPA - ACAM NACI Recommendations on COVID-19 Vaccine Interchangeability.// (2021, June 18). Canadian Association of Physician Assistants. https://archive.ph/O1LY8))
+On October 27, 2021, she participated in a webinar discussing flu shots in the 2021/2022 influenza season.((//PHAC webinar for health care providers: seasonal influenza immunization 2021-2022.// (2021, October 20). National Collaborating Centre for Infectious Diseases. https://archive.ph/OhdMH )) The video, posted to the [[YouTube]] channel for the National Collaborating Centre for Infectious Diseases, reveals that the [[Public Health Agency of Canada]] and NACI were aiming for an 80% rate of flu vaccine uptake.((NCCID • CCNMI. (2021, November 29). //PHAC Webinar for Health Care Providers: Seasonal Influenza Immunization 2021-2022.// YouTube. https://web.archive.org/web/20220321165148/https://www.youtube.com/watch?v=Mlg0YDT9nRg))
+She has received repayment for travel expense totalling less than $1,000 from PHAC since 2017.
+===== Research =====
+Dr. Harrison’s areas of study include infection prevention, workplace health and safety, and immunizations.
+==== Antimicrobial Resistance ====
+Dr. Harrison is an Editorial Contributor/Reviewer for an [[antimicrobial resistance]] project called [[Bugs & Drugs]].((//B&D - The App.// Bugs and Drugs. Retrieved March 24, 2022, from https://archive.ph/h9lq7)) Other team members include:
+  * [[public_health_agencies:canada:John Conly of the AHS Scientific Advisory Group for COVID-19
+  * [[public_health_agencies:canada:Andrew Morris]] of the [[Ontario COVID-19 Science Advisory Table]]
+  * [[public_health_agencies:canada:Lynora Saxinger]] of the AHS Scientific Advisory Group for COVID-19
+The project was funded by [[public_health_agencies:canada:Alberta Health Services]], [[Alberta Health]], and the [[BC Ministry of Health]], Pharmaceutical Services Division.
+==== COVID-19 ====
+Dr. Harrison is a site investigator for [[Canadian COVID-19 Cohort Study]] (CCCS), studying the epidemiology of [[COVID-19]] in Canadian healthcare workers.((//Edmonton - Canadian COVID-19 Cohort Study (CCCS): Study of the epidemiology of COVID-19 in Canadian healthcare workers.// TIBDN: Toronto Invasive Bacterial Diseases Network. Retrieved March 21, 2022, from https://archive.ph/3u0sv)) The specific items for research include the rate of COVID-19 infection, risk factors for infection (occupational and community), antibody levels over time, uptake of [[vaccines]] against COVID-19, and psychological impact of working during a [[pandemic]]. Dr. Harrison’s study group includes staff working at either [[Grey Nuns Community Hospital]] or the [[University of Alberta Hospital]].
+The CCCS study page bearing Dr. Harrison’s name is hosted on the website for the [[Toronto Invasive Bacterial Diseases Network]] at [[Mount Sinai Hospital]], which is funded by “an unrestricted educational grant from [[pharmaceutical_companies:Pfizer|Pfizer Canada Inc]].”